Tyrosine kinase inhibitors (TKI) are employed to attack specific types of cancer cells. The downside to using TKs is that they can cause serious inflammation. A team of researchers has discovered the underlying mechanism that causes this inflammation.
How TKI cancer drugs cause inflammatory side effects
- 17. 3 2023 (19:50)